Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Effects of baicalin on the proliferation of extranodal NK/T-cell lymphoma cells and the sensitivity of the cells to the drug

Xiaohui Duan, Jianhong Wang, Yao Lv, Jing Liu, Shixiong Wang, Zhentian Wu, Binxuan Wang, Ming Lu, Na Yang, Xinwei Liu, Zheshen Lin, Yeye Li, Rong Liang

Department of Hematology, Xijing Hospital, First Affiliated Hospital of Air Force Military Medical University, No. 127, Changle West Road, Xincheng District, Xi'an City, Shaanxi Province; Xi'an, Shaanxi 710032, China;

For correspondence:-  Rong Liang   Email: lurongfen057665@126.com

Accepted: 24 February 2023        Published: 31 March 2023

Citation: Duan X, Wang J, Lv Y, Liu J, Wang S, Wu Z, et al. Effects of baicalin on the proliferation of extranodal NK/T-cell lymphoma cells and the sensitivity of the cells to the drug. Trop J Pharm Res 2023; 22(3):485-492 doi: 10.4314/tjpr.v22i3.4

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To evaluate the effect of baicalin on the proliferation of extranodal NK/T-cell lymphoma cells and the sensitivity of the cells to the drug.
Methods: Cell-counting-kit (CCK) assay was used to determine cell activity, while the antagonistic, superimposed and synergistic effects of drug combinations were investigated by coefficient of drug interaction (CDI). Cell proliferation was assessed using 5-ethynyl-2’- deoxyuridine (EdU) test. Flow cytometry was carried out to determine the apoptosis of studied extranodal NK/T-cell lymphoma cells. Furthermore, western-blot was used to evaluate the expression levels of BCL2, BAX, cleaved-caspase3 and caspase3 of the cells.
Results: Survival of SNK-6 and YTS cells decreased gradually in a concentration-dependent manner (r = -0.97 and -0.98). Cell viability at the same concentration diminished with time, but with increase in cisplatin concentration, cell viability at the same time point also decreased. At cisplatin concentrations of 5, 10, and 20 μmol/L, reduction in cell viability between the two groups were significantly different (p < 0.001). Furthermore, the proliferation of SNK-6 and YTS cells decreased with increasing baicalin concentrations while apoptosis of the cells increased with increasing baicalin concentration.
Conclusion: Baicalin inhibits the proliferation but promotes the apoptosis of SNK-6 and YTS cells. Cisplatin plus baicalin lowers cell proliferation rate and increase the apoptosis rate of both SNK-6 and YTS cells compared with baicalin or cisplatin alone. This drug combination should be further explored for its apoptosis potential in animal models.

Keywords: Baicalin, Proliferation, Extranodal NK/T-cell lymphoma cells, Drug sensitivity

Impact Factor
Thompson Reuters (ISI): 0.523 (2021)
H-5 index (Google Scholar): 39 (2021)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates